Serum HER2 Level Predicts Therapeutic Efficacy and Prognosis in Advanced Breast Cancer Patients
Shuling Wang,1,2,* Yuqin Chen,1– 3,* Weidong Li,2,4,* Chunfang Hao,1,2 Li Zhang,1,2 Weipeng Zhao,1,2 Yehui Shi,1,2 Zhongsheng Tong1,2 1Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key La...
Main Authors: | Wang S, Chen Y, Li W, Hao C, Zhang L, Zhao W, Shi Y, Tong Z |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2024-04-01
|
Series: | Breast Cancer: Targets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/serum-her2-level-predicts-therapeutic-efficacy-and-prognosis-in-advanc-peer-reviewed-fulltext-article-BCTT |
Similar Items
-
Serum HER2 Level Predicts Therapeutic Efficacy and Prognosis in Advanced Breast Cancer Patients [Letter]
by: Syahruddin FI, et al.
Published: (2024-04-01) -
Clinicopathological features and prognosis of patients with HER2-low breast cancer
by: Xin Yang, et al.
Published: (2023-09-01) -
Clinicopathological characteristics and prognosis of early-stage HER2 low-expression breast cancer: A single-center retrospective study
by: Chang-Gen Liu, et al.
Published: (2023-03-01) -
Analysis of the clinicopathological characteristics and prognosis of triple-positive breast cancer and HER2-positive breast cancer—A retrospective study
by: Dongxu Ma, et al.
Published: (2023-01-01) -
In Real Life, Low-Level HER2 Expression May Be Associated With Better Outcome in HER2-Negative Breast Cancer: A Study of the National Cancer Center, China
by: Yiqun Li, et al.
Published: (2022-01-01)